The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements.
Di Fusco, D., Ciccacci, C., Rufini, S., Forte, V., Novelli, G., Borgiani, P. (2013). Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses. THROMBOSIS RESEARCH, 132(1), 123-126 [10.1016/j.thromres.2013.05.002].
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses
CICCACCI, CINZIA;FORTE, VIVIANA;NOVELLI, GIUSEPPE;BORGIANI, PAOLA
2013-07-01
Abstract
The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
140.08 kB
Formato
Adobe PDF
|
140.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
